Vacuum Blood Collection Devices Market by Product (Serum Separation Tubes, Serum Clot Activators/Serum Gel + Clot Activator, Plasma Analysis/Anti-coagulants), Material (PET/Plastic, Glass), Application (Serology & Immunology, Routine Chemistry), End User & Region - Forecast to 2021-2031

Global Vacuum Blood Collection Devices Market Snapshot

The global Vacuum Blood Collection Devices Market will total US$ 2.3 Bn in 2021 and is expected to register growth at 6.3% CAGR during the forecast period (2021-2031). Increasing blood transfusion, growing adoption of blood test, demand for reliable and safe blood collection equipment, and surging adoption of aseptic techniques to offer improved patient will drive the vacuum blood collection devices market.

With rising number of blood tests performed for the diagnosis of chronic diseases such as human immunodeficiency virus (HIV), anemia, diabetes, and cardiovascular diseases, sales of vacuum blood collection devices are forecast to reach US$ 4.2 Bn by the end of 2031.

Key Points Covered in Vacuum Blood Collection Devices Study

• Market estimates and forecast 2016-2031
• Key drivers and restraints impacting market growth
• Segment-wise, Country-wise, and Region-wise Analysis
• Competition Mapping and Benchmarking
• Market Share Analysis
• Key Product Innovations and Regulatory Climate
• COVID-19 Impact on vacuum blood collection devices and How to Navigate
• Recommendation on Key Winning Strategies

Request comprehensive report brochure

2021-2031 Vacuum Blood Collection Devices Demand Outlook Compared to Growth Exhibited in 2016-2020

According to Future Market Insights (FMI), the demand for vacuum blood collection devices grew at a CAGR of around 4.2% between 2016 and 2020. Increasing health check-ups due to rising prevalence of chronic diseases, ease in sample collection and processing, and new product launches are the chief drivers, boosting the sales of vacuum blood collection devices.

As blood is considered a gold standard for diagnosis of infectious diseases and various other medical conditions, sales of vacuum blood collection devices market have been witnessing significant growth during the pandemic phase. Factors such as these will create a positive influence on the growth of the global vacuum blood collection devices market

With positive impact of COVID-19 on the global vacuum blood collection devices market, Future Market Insights projects the market to register healthy growth at a CAGR of 6.3% by the end of 2031.

How Will Preference for Non-Invasive Techniques and Liquid Biopsy for Disease Diagnosis Reshape Growth?

Rising prevalence of cancer has encouraged people for early diagnosis tests. With growing awareness regarding the benefits of non-invasive test procedures, patients are opting for non-invasive diagnostic tools.

Among these, liquid biopsy has emerged as a promising and versatile non-invasive cancer diagnostic tool. Liquid biopsy analysis is based on circulating cell-free nucleic acids, circulating tumor cells or other diseased cells from organs. This technique is especially acquiring immense popularity among geriatric population.

With growing number of stabilizing reagents and easy availability of vacuum blood collection devices, non-invasive diagnostic procedures have become easily accessible. As vacuum blood collection devices allow to perform post-collection preservation of circulating cell-free DNA (cfDNA), medical professionals are increasingly advising liquid biopsy for cancer patients.

The evolution of the vacuum blood collection tube market is dependent on the requirements for blood preservation after sample collection which increases the interest to perform non-invasive diagnostic procedures. Advancements such as these are expected to provide promising opportunity for the vacuum blood collection devices market.

What are the Key Trends Driving the Sales of Vacuum Blood Collection Devices?

Key players are focusing on developing technologically advanced and innovative products by investing in research and development (R&D) activities to gain competitive advantage. Increasing investment in R&D by biotechnology companies is also expected to provide ample of growth opportunities for the market players.

Improvement and streamlining of regulatory processes and growing funding for life science research in developing countries are expected to boost product portfolio and development of vacuum blood collection devices.

As key players are focusing on collaborations and acquisition of regional distributors and other manufacturers for global expansion, the market is expected to witness impressive growth opportunities over the coming years.

What is the Impact of the COVID-19 Crisis on the Market?

The COVID-19 pandemic is expected to have moderately positive impact on vacuum blood collection devices market as the diagnostics industry has found itself on the frontline to deal with the global medical emergency. However, adding to already existing challenges are closed transnational borders, lengthy custom procedures, halted distribution channels, and limited stock of raw materials supplies.

As blood is considered a gold standard for diagnosis of infectious diseases and various other medical conditions, sales of vacuum blood collection devices have been witnessing significant growth during the pandemic. Factors such as these will create a positive influence on the growth of the global vacuum blood collection devices market.

Country-wise Insight

Will the U.S. Remain a Key Market for Vacuum Blood Collection Devices?

In 2021, the U.S. is expected to emerge as one of the most lucrative markets, accounting for a market share of over 87.3 % across North America. Growth in the country is driven by growing popularity of health checkup due to rise in lifestyle and chronic disorders.

With advancement in biotechnology and ease in sample collection and processing, growth exhibited by the vacuum blood collection devices market is expected to improve. Presence of numerous key players in the country is the other factor driving the growth of the market in this region.

Will Germany Continue Exhibiting High Demand for Vacuum Blood Collection Devices?

Germany is projected to dominate the Europe vacuum blood collection devices market, holding over 18.9% of the market share in 2021. Growth can be attributed to the factors such as increasing medical applications, growing product launches, technological advancements in biotechnological industry, and growing prevalence of chronic diseases in the country.

What are the Factors Supporting the Growth in the China?

The vacuum blood collection devices market in China is poised to expand at 9.7% CAGR through 2031. Demand is projected to rise due to the increase in number of diagnosis and physical examination.

Additionally, high disposable incomes, favorable government policies, new product launches, and rise in government funding for life science research will boost the market. Growing product penetration and health awareness are among the major factors driving market growth in China.

How will the Vacuum Blood Collection Devices Market Expand in India?

The vacuum blood collection devices in India is likely to grow at a CAGR of 8.2% during the forecast period. With a market share of over 69.3% in 2021, India is expected to spearhead the growth of South Asia.

Key factors aiding growth is rising prevalence of infectious and chronic diseases in the country, outbreak of contagious diseases such as COVID-19, and rising focus on improving overall healthcare infrastructure.

Category-wise Insights

Why is Demand for Serum Separation Tubes Rising?

In terms of product, the serum separation tubes will hold the maximum share of 24.1%, expanding at 6.7% CAGR during the forecast period. As these serum separator tubes (SST) provide rapid separation of serum from cellular constituents of blood, medical professionals are extensively using them for the diagnosis of contagious diseases.

A plethora of benefits such as easy transportation, minimal need of aliquoting serum, and reduction of analytical errors are making serum separation tubes highly sought-after in the vacuum blood collection devices market.

PET/Plastic to Remain Preferred Material for Vacuum Blood Collection Devices

In terms of material, plastic/PET material is projected to account for 84.5% of the market share in 2021. Demand in this segment will continue increasing due to PET material’s resistance to breakage and high steam sterilization tolerance. Also it can sustain cold storage temperatures without mechanical fatigue and deformation, which makes it ideal for vacuum blood collection devices.

Which is the Key Application of Vacuum Blood Collection Devices?

In terms of application the routine chemistry will account for 34.2% of the market share in 2021. Routine chemistry is used to evaluate the body's electrolyte balance and the status of several major body organs and empower individuals to make informed decisions about health. Also, this application segment is expected to grow at a highest CAGR of 7.1% during the forecast period.

Who is the Leading End User of Vacuum Blood Collection Device?

In terms of end user, diagnostic laboratories will account for 46.6% of the market share in 2021. Demand in the segment will continue increasing due to rising prevalence of various diseases such as diabetes, hepatitis B, cancer, heart diseases, and HIV AIDS, whose diagnosis requires various blood tests to confirm the severity of the disease.

Competitive Landscape

New product launches & approvals have emerged as key growth strategy adopted by the leading players in the vacuum blood collection devices market. Followed by this, acquisition was the second most common strategy adopted by the industry players. For instance:

• In November 2020, Intervactechonlogy OU introduced new packaging system for its blood collection devices set. The packaging is available in paper, plastic, plastic blister, and foil pack for 1, 2, and 5 tube pack.
• In June 2018, Poly Medicure acquired Plan 1 Health S.R.L., one of the leading medical device players operating in Italy. This acquisition will help company to expand its geographical reach as well as enhance its portfolio in the medical device industry region. Further, as per agreement, Plan 1 Health S.R. L. will now operate as a subsidiary of Poly Medicure B.V, and indirect subsidiary of Poly Medicure Limited.
• In June 2021, Sekisui Medical acquired Veredus Laboratories Pte.Ltd., a testing company based out of Singapore. This acquisition enabled the company to strengthen their presence in the Asian economies.

The market is consolidated and is dominated by players such as

• Becton
• Dickinson & Company
• Greiner Bio-One GmbH
• Guangzhou Improve Medical Instruments Co.,Ltd
• AB Medical, Inc.
• SARSTEDT AG & Co. KG
• Cardinal Health
• Poly Medicure Ltd
• FL Medical
• InterVac Technology
• CHENGDU RICH SCIENCE INDUSTRY CO., LTD.
• Zhejiang Gongdong Medical Technology Co. Ltd.
• Aptaca Spa. 
• Hindustan syringes & Medical Devices.

In March 2018, BD upgraded its instruction for its BD Vacutainer tubes as a part of its quality process, which ensures appropriate use of these tubes.

Scope of Report

Vacuum Blood Collection Devices by Category

By Product:

• Serum Separation Tubes
• Serum Clot Activators/Serum Gel + Clot Activator
  • Silica
  • Thrombin
• Plasma Analysis/Anti-coagulants
  • EDTA Tubes
  • Lithium Heparin
  • Sodium Heparin
• Coagulation Analysis Tubes
• Glucose Analysis Tubes
  • Sodium Fluoride
  • Potassium Fluoride
  • Fluoride Oxide
• Others

By Material:

• PET/Plastic
• Glass

By Application:

• Serology & Immunology
• Routine Chemistry
• Blood Typing
• Molecular Genetics
• Blood Sugar Assay
• Others

By End User :

• Diagnostic Centers
• Hospitals & Clinics
• Research & Academic Institutes
• Veterinary Hospitals & Clinics

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)